Euvichol-S, the newly approved oral cholera vaccine by the World Health Organization (WHO), offers a simpler and cheaper alternative to its predecessor, Euvichol-Plus, marking a significant advancement in global cholera prevention efforts.
About Euvichol-S:
- This new vaccine is simpler and cheaper than its predecessor, Euvichol-Plus.
- It uses fewer ingredients and can be produced more quickly.
- Euvichol-S is part of a family of inactivated oral cholera vaccines, which includes Euvichol and Euvichol-Plus.
- It is the third vaccine from this family to be prequalified by the WHO.
About Cholera:
- Cholera is a severe diarrheal disease caused by Vibrio cholerae bacteria. It leads to acute watery diarrhoea, vomiting, and leg cramps.
- The disease spreads through contaminated food or water and poses a significant global public health threat.
- Cholera is prevalent in regions with poor sanitation and limited clean water access, mainly in the Middle East and Africa.
- As of July 2023, India had reported 132 cholera cases, highlighting its ongoing global impact.
Ref:Source
| UPSC IAS Preparation Resources | |
| Current Affairs Analysis | Topperspedia |
| GS Shots | Simply Explained |
| Daily Flash Cards | Daily Quiz |